AstraZeneca treatments win orphan FDA status
Bloomberg Two AstraZeneca Plc cancer drugs received orphan status for treatment of liver cancer, a designation that may eventually speed progress to approval. The US Food and Drug Administration (FDA) granted the special status reserved for rare conditions to Imfinzi, a lung cancer treatment, and tremelimumab, which has been tested in a combination in a variety of cancers, AstraZeneca said ...
Read More »